KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addus HomeCare (ADUS) Other Accumulated Expenses (2016 - 2025)

Addus HomeCare (ADUS) has disclosed Other Accumulated Expenses for 14 consecutive years, with $14.5 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Other Accumulated Expenses changed N/A year-over-year to $14.5 million, compared with a TTM value of $14.5 million through Jun 2025, changed N/A, and an annual FY2024 reading of $12.4 million, up 42.28% over the prior year.
  • Other Accumulated Expenses was $14.5 million for Q2 2025 at Addus HomeCare, up from $12.4 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $14.5 million in Q2 2025 and bottomed at $5.1 million in Q1 2021.
  • Average Other Accumulated Expenses over 5 years is $8.9 million, with a median of $7.7 million recorded in 2022.
  • The sharpest move saw Other Accumulated Expenses surged 125.43% in 2021, then tumbled 59.24% in 2022.
  • Year by year, Other Accumulated Expenses stood at $12.6 million in 2021, then crashed by 59.24% to $5.2 million in 2022, then surged by 69.68% to $8.7 million in 2023, then soared by 42.28% to $12.4 million in 2024, then increased by 16.9% to $14.5 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for ADUS at $14.5 million in Q2 2025, $12.4 million in Q4 2024, and $8.7 million in Q4 2023.